Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

170 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Dose density and dose intensity in the treatment of breast cancer].
Saintigny P, Assouad S, Gligorov J, Selle F, Roché H, Breau JL, Morère JF, Lotz JP. Saintigny P, et al. Among authors: morere jf. Bull Cancer. 2004 Dec 1;91 Suppl 4:S244-53. Bull Cancer. 2004. PMID: 15899616 Free article. Review. French.
Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301).
Des Guetz G, Landre T, Westeel V, Milleron B, Vaylet F, Urban T, Barlesi F, Souquet PJ, Debieuvre D, Braun D, Fraboulet G, Monnet I, Uzzan B, Molinier O, Morin F, Moro-Sibilot D, Morère JF. Des Guetz G, et al. Among authors: morere jf. J Geriatr Oncol. 2015 May;6(3):233-40. doi: 10.1016/j.jgo.2015.02.002. Epub 2015 Feb 16. J Geriatr Oncol. 2015. PMID: 25698450 Clinical Trial.
Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project.
Innominato PF, Komarzynski S, Mohammad-Djafari A, Arbaud A, Ulusakarya A, Bouchahda M, Haydar M, Bossevot-Desmaris R, Plessis V, Mocquery M, Bouchoucha D, Afshar M, Beau J, Karaboué A, Morère JF, Fursse J, Rovira Simon J, Levi F. Innominato PF, et al. Among authors: morere jf. J Med Internet Res. 2016 Nov 25;18(11):e305. doi: 10.2196/jmir.6303. J Med Internet Res. 2016. PMID: 27888171 Free PMC article.
170 results